PSMA6 and benign prostatic hyperplasia: In addition, among male participants, alpha-1 blocker users with hypertension conferred a significantly increased risk for RCC only when the patients did not have BPH (HR, 1.63; 95% CI, 1.22−2.18; P < .001).